What is the clinical significance of being an ultra-rapid CYP2D6 metabolizer? {Ans: People who are ultra-rapid metabolizers have high activity of CYP2D6 enzymes that break down certain medicines rapidly and are likely to need different doses or even a different medicine. Drug dose, response, and toxicity risk of beta-blockers, antidepressants, antiarrhythmics, and opioid analgesics are dependent on CYP2D6 pharmacogenetics (Ayazseven et al., 2020). Knowing the result of the CYP2D6 test and which group the patient falls into such as poor metabolizers, intermediate metabolizers, or ultra-rapid metabolizers, will help nurse practitioners prescribe the right medication and dosage for the patient.}o {Ans: Decreasing the activity of the opposing system}Key points: {Ans: However, we need to consider the patient as an individual, and co-morbidities have a central role in the decision process}What out text has to say about National Standards of Culturally and Linguistically Appropriate Services? {Ans: In 2012, the institute of medicine identified that the main factor affecting health disparity is cultural competency of the health practitioner (Woo & Robinson, 2016). The National Standard for Culturally and Linguistically Appropriate Services in health and health care (CLAS) standards were created as a way to address and correct these inequities